State Program Monitoring
State-level monitoring bodies overseeing licensed psychedelic therapy programmes and ensuring compliance.
All Organisations
Colorado DORA Natural Medicine Program
Colorado Division of Professions and Occupations program overseeing facilitator licensing, renewals, complaints, and rule/policy resources for natural medicine services.
Colorado Department of Natural Medicine (DOR)
Colorado Department of Revenue division responsible for licensing and regulating natural medicine businesses, including healing centers, cultivations, product manufacturers, and testing facilities.
European Union Drugs Agency (EUDA)
EU-level drug monitoring authority publishing surveillance and risk intelligence on hallucinogens, including LSD-related trends and associated policy-relevant evidence streams.
Health Canada
Canadian federal health regulator administering Special Access Program pathways for restricted drugs, including psychedelic substances under case-by-case clinical access conditions.
Oregon Health Authority
Oregon public health authority operating Oregon Psilocybin Services (OPS), with statutory responsibilities for licensing, regulation, and oversight of psilocybin service delivery under ORS 475A.
Swiss Federal Office of Public Health (FOPH)
Swiss federal authority issuing exceptional licences for otherwise prohibited narcotics, including controlled pathways relevant to psychedelic substances under medical/scientific exceptions.
Therapeutic Goods Administration (TGA)
Australian national regulator implementing schedule controls and authorised-prescriber pathways relevant to MDMA and psilocybin use in tightly regulated psychiatric indications.